John Ballantyne

532 total citations
14 papers, 382 citations indexed

About

John Ballantyne is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, John Ballantyne has authored 14 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in John Ballantyne's work include Viral Infections and Vectors (7 papers), Viral Infections and Outbreaks Research (7 papers) and Bacillus and Francisella bacterial research (2 papers). John Ballantyne is often cited by papers focused on Viral Infections and Vectors (7 papers), Viral Infections and Outbreaks Research (7 papers) and Bacillus and Francisella bacterial research (2 papers). John Ballantyne collaborates with scholars based in United States, Chile and France. John Ballantyne's co-authors include Jay W. Hooper, Matthew Josleyn, Rebecca L. Brocato, Michael Royals, Steven A. Kwilas, Steve Kwilas, Joseph W. Golden, Pablo Vial, Christopher Hammerbeck and Hua Wu and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

John Ballantyne

14 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Ballantyne United States	12	275	71	67	59	59	14	382
Rebecca Surtees United Kingdom	10	253 0.9×	95 1.3×	106 1.6×	23 0.4×	125 2.1×	14	420
Jin Won Song South Korea	10	300 1.1×	53 0.7×	91 1.4×	25 0.4×	65 1.1×	17	466
Kathleen Kuehl United States	11	314 1.1×	66 0.9×	93 1.4×	14 0.2×	59 1.0×	15	430
Lorena Tomé-Poderti Uruguay	6	123 0.4×	70 1.0×	43 0.6×	16 0.3×	58 1.0×	13	303
Olaf Niederstraßer Germany	5	144 0.5×	38 0.5×	162 2.4×	37 0.6×	32 0.5×	6	294
Shumpei Watanabe Japan	10	316 1.1×	27 0.4×	103 1.5×	76 1.3×	74 1.3×	15	407
Ivano Broz Australia	6	277 1.0×	31 0.4×	242 3.6×	64 1.1×	127 2.2×	6	387
Sami Kukkonen Finland	10	419 1.5×	54 0.8×	25 0.4×	66 1.1×	124 2.1×	11	523
Prasad Sarkale India	12	392 1.4×	42 0.6×	102 1.5×	33 0.6×	123 2.1×	27	442
Satoko Yamaoka Japan	12	244 0.9×	48 0.7×	113 1.7×	202 3.4×	29 0.5×	18	390

Countries citing papers authored by John Ballantyne

Since Specialization

Citations

This map shows the geographic impact of John Ballantyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ballantyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ballantyne more than expected).

Fields of papers citing papers by John Ballantyne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Ballantyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ballantyne. The network helps show where John Ballantyne may publish in the future.

Co-authorship network of co-authors of John Ballantyne

This figure shows the co-authorship network connecting the top 25 collaborators of John Ballantyne. A scholar is included among the top collaborators of John Ballantyne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Ballantyne. John Ballantyne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Mucker, Eric M., Priya Karmali, Jerel Vega, et al.. (2020). Lipid Nanoparticle Formulation Increases Efficiency of DNA-Vectored Vaccines/Immunoprophylaxis in Animals Including Transchromosomic Bovines. Scientific Reports. 10(1). 8764–8764. 35 indexed citations

Terman, David S., et al.. (2020). Endogenous HLA-DQ8αβ programs superantigens (SEG/SEI) to silence toxicity and unleash a tumoricidal network with long-term melanoma survival. Journal for ImmunoTherapy of Cancer. 8(2). e001493–e001493. 3 indexed citations

Stein, Derek R., Joseph W. Golden, Bryan D. Griffin, et al.. (2017). Human polyclonal antibodies produced in transchromosomal cattle prevent lethal Zika virus infection and testicular atrophy in mice. Antiviral Research. 146. 164–173. 20 indexed citations

Golden, Joseph W., Piet Maes, Steven A. Kwilas, John Ballantyne, & Jay W. Hooper. (2016). Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever. Journal of Virology. 90(7). 3515–3529. 23 indexed citations

Haese, Nicole N., Rebecca L. Brocato, Matthew L. Nilles, et al.. (2015). Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure. PLoS neglected tropical diseases. 9(6). e0003803–e0003803. 39 indexed citations

Kwilas, Steve, et al.. (2014). A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates. Current Gene Therapy. 14(3). 200–210. 45 indexed citations

Hooper, Jay W., Rebecca L. Brocato, Steven A. Kwilas, et al.. (2014). DNA vaccine–derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome. Science Translational Medicine. 6(264). 264ra162–264ra162. 49 indexed citations

Hooper, Jay W., Matthew Josleyn, John Ballantyne, & Rebecca L. Brocato. (2013). A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS). Vaccine. 31(40). 4314–4321. 46 indexed citations

Groot, Anne S. De, Leo Einck, Leonard Moise, et al.. (2013). Making vaccines “on demand”. Human Vaccines & Immunotherapeutics. 9(9). 1877–1884. 15 indexed citations

10.

Brocato, Rebecca L., Matthew Josleyn, John Ballantyne, Pablo Vial, & Jay W. Hooper. (2012). DNA Vaccine-Generated Duck Polyclonal Antibodies as a Postexposure Prophylactic to Prevent Hantavirus Pulmonary Syndrome (HPS). PLoS ONE. 7(4). e35996–e35996. 44 indexed citations

11.

Golden, Joseph W., Marina Zaitseva, Senta M. Kapnick, et al.. (2011). Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease. Virology Journal. 8(1). 441–441. 31 indexed citations

12.

Xu, L., Wenge Zhang, Susan Tang, et al.. (2011). A Directed Molecular Evolution Approach to Improved Immunogenicity of the HIV-1 Envelope Glycoprotein. PLoS ONE. 6(6). e20927–e20927. 13 indexed citations

13.

Chen, Helen, L. Xu, Terri Wrin, et al.. (2009). Effect of trimerization motifs on quaternary structure, antigenicity, and immunogenicity of a noncleavable HIV-1 gp140 envelope glycoprotein. Virology. 395(1). 33–44. 17 indexed citations

14.

Ballantyne, John. (2006). Practical Methods for Supercoiled pNDA Production. Humana Press eBooks. 127. 311–338. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact